Why Drinking More Water Won't Stop Kidney Stones

Every doctor says it. Every pamphlet repeats it. Pass a kidney stone and the first instruction you'll get is to drink more water. That advice isn't wrong — but a 2025 clinical study published in the journal Diagnostics makes a pretty compelling case that it's been crowding out something more important. Among 98 stone-forming patients whose urine was analyzed one month after surgical removal, the most common metabolic abnormality wasn't dehydration. It was a shortage of citrate — a natural crystal-blocking compound that the kidneys produce — found in over six in ten patients. Drinking more water can't fix that.

The Recurrence Problem Nobody Warned You About

Kidney stones are common — roughly one in ten people will deal with them at some point — and they have a stubborn tendency to come back. Studies put the five-to-ten-year recurrence rate at around 50%, climbing to 75% over twenty years. Pediatric patients do even worse: about half experience a recurrence within three years of their first episode. Kidney stone care in the United States already costs roughly five billion dollars annually, and that number is climbing. The standard prevention advice — hydrate, cut back on salt and red meat, avoid oxalate-rich foods — is reasonable as far as it goes. The trouble is that it treats every stone former the same way, as if all stones come from the same source. They don't.

Why "Just Drink More Water" Falls Short

The new study, led by researchers at North-Western State Medical University in St. Petersburg, analyzed complete 24-hour urine samples from 98 patients roughly one month after endoscopic kidney stone removal. They measured fifteen separate urinary parameters — volume, pH, calcium, oxalate, citrate, magnesium, sodium, and more — to build a full metabolic picture of what each patient's urine actually looked like during the period when stones are most likely to reform. Low urine volume came up a lot, showing up in 53% of patients. That's significant. But it wasn't the leading problem. Hypocitraturia — a shortage of the natural stone inhibitor citrate — appeared in 61.2% of patients, edging out dehydration as the most prevalent urinary abnormality in the cohort. High urine calcium came in third, affecting 50%.

Why Does Citrate Deficiency Drive More Stones Than Low Fluid Intake?

Citrate works as a kind of chemical bodyguard in the kidney. It binds free calcium ions before they can link up with oxalate, essentially intercepting the raw materials that calcium oxalate stones need to grow. When citrate levels are low — whether from metabolic acidosis, a high-protein diet, or certain medications — that protection disappears, and the environment inside the kidney becomes favorable for crystal formation even when a person is drinking a normal amount of fluid. Separate research published in the American Journal of Kidney Diseases in 2024, which drew on over 9,000 urine samples across three large prospective cohorts, ranked calcium, urine volume, and citrate as the three most influential urinary factors in stone formation. Oxalate — the compound most patients are warned about — actually ranked fourth. That's a ranking that might surprise your average urologist, let alone a patient who's been told to lay off the spinach.

What Changes When You Know Your Urine Chemistry

The practical implication is fairly direct. A patient with hypocitraturia needs a different intervention than one whose main problem is low fluid volume or elevated calcium. Potassium citrate supplementation can raise urinary citrate levels and has shown real efficacy in reducing recurrence — but it only helps people who actually have a citrate deficit. For those whose dominant issue is high urinary oxalate, research suggests that dietary changes — cutting spinach, almonds, rhubarb, and high-dose vitamin C supplements — can meaningfully reduce oxalate excretion. Dietary calcium, counterintuitively, should stay adequate: around 1,000–1,200 mg per day from food, eaten alongside oxalate-containing meals so the calcium can bind the oxalate in the gut before the kidneys ever see it. The key word is "personalized." A blanket recommendation issued without knowing what's actually in a patient's urine is a guess, not a treatment plan.

The Open Questions — and What Comes Next

The St. Petersburg study has real limits worth naming. It was 98 patients, all calcium oxalate stone formers, predominantly post-surgical — a narrow slice of the full spectrum of kidney stone disease. The researchers did not find statistically significant metabolic differences between the two subtypes of calcium oxalate stone (monohydrate versus dihydrate), with one exception: oxalate concentration differed between the groups in a way that was statistically meaningful. That single divergence hints that even within the calcium oxalate category, there may be biologically distinct subtypes that warrant different treatment approaches. What it doesn't yet tell us is whether treating each metabolic abnormality in isolation actually reduces recurrence rates — that requires randomized controlled trials, several of which are currently underway. Until then, the most actionable step for anyone who has passed a stone is to push for a full 24-hour urine panel, not just a hydration recommendation and a handshake.

• Citrate, not just water — Low citrate was the most common urinary abnormality in stone formers, present in 61% of patients, outranking low fluid intake and high calcium.
• Your stones have a specific chemistry — Generic advice doesn't address personalized metabolic deficits; a 24-hour urine test reveals what's actually driving recurrence.
• Oxalate risk is continuous — Even within the normal range, each additional 4 mg per day of urinary oxalate can raise stone risk by 60–100%, making incremental dietary changes genuinely worthwhile.

"By identifying potential metabolic distinctions, we hope to contribute to the optimization of stone prevention strategies, ultimately reducing recurrence rates and improving patient care." — Gadzhiev et al., Diagnostics, 2025.